Inhibition of Cardiac Vagal Effects by Neurally Released and Exogenous Neuropeptide Y

Circulation Research - United States
doi 10.1161/01.res.65.6.1536
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Neuropeptide Y as a Putative Modulator of the Vagal Effects on Heart Rate

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1989English

Vagal Stimulation Targets Select Populations of Intrinsic Cardiac Neurons to Control Neurally Induced Atrial Fibrillation

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2016English

Α1-Adrenoceptor Subtypes Involved in Vasoconstrictor Responses to Exogenous and Neurally Released Noradrenaline in Rat Femoral Resistance Arteries

British Journal of Pharmacology
Pharmacology
2004English

Acetylstrophanthidin-Induced Reflex Inhibition of Canine Renal Sympathetic Nerve Activity Mediated by Cardiac Receptors With Vagal Afferents

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1979English

Transcellular Induction of Neuropeptide Y Expression by NT4 and BDNF

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Effects of Drugs of Abuse on the Central Neuropeptide Y System

Addiction Biology
MedicinePsychiatryMental HealthPharmacology
2017English

Neuropeptide Y (NPY)

Science-Business eXchange
2009English

Genetic Studies of Neuropeptide Y and Neuropeptide Y Receptors Y1 and Y5 Regions in Morbid Obesity

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1997English

Neuropeptide Regulation of Fear and Anxiety: Implications of Cholecystokinin, Endogenous Opioids, and Neuropeptide Y

Physiology and Behavior
PhilosophyBehavioral NeuroscienceExperimentalCognitive Psychology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy